Macrophage Migration Inhibitory Factor Regulates U1 Small Nuclear RNP Immune Complex-Mediated Activation of the NLRP3...

Area of Science:

• Immunology
• Molecular Biology
• Rheumatology

Background:

• High-expression alleles of macrophage migration inhibitory factor (MIF) are linked to systemic lupus erythematosus (SLE) severity.
• U1 small nuclear RNP (snRNP) immune complexes activate the NLRP3 inflammasome in monocytes, leading to interleukin-1β (IL-1β) production in SLE patients.

Purpose of the Study:

• Investigate the role of snRNP immune complexes in up-regulating MIF expression.
• Elucidate the interface between MIF and the NLRP3 inflammasome in SLE pathogenesis.

Main Methods:

• Analyzed MIF, IL-1β, NLRP3, caspase 1, ASC, and MIF receptors using ELISA, Western blotting, qPCR, and CytoF.
• Probed MIF pathway responses using the small molecule antagonist MIF098.

Main Results:

• snRNP immune complexes induced MIF and IL-1β production in human monocytes.
• MIF was found to regulate NLRP3 inflammasome activation and IL-1β levels.
• MIF098 suppressed IL-1β production, NLRP3 up-regulation, and caspase 1 activation.

Conclusions:

• U1 snRNP immune complexes specifically stimulate MIF production in monocytes.
• MIF plays an upstream role in monocyte activation by regulating NLRP3 inflammasome and IL-1β production.
• Targeting MIF offers a therapeutic strategy for specific SLE patient subgroups.